Developing useful highly active antiretroviral therapy adherence measures for India: The prerana study

Journal of Acquired Immune Deficiency Syndromes

Volumn 53, Issue 3, 2010, Pages 415-417

  Ekstrand, Maria L ^a   Chandy, Sara ^b   Heylen, Elsa ^a   Steward, Wayne ^a   Singh, Girija ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ANTIVIRAL RESISTANCE; BEHAVIOR CHANGE; CD4 LYMPHOCYTE COUNT; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; LETTER; MAJOR CLINICAL STUDY; NON PROFIT ORGANIZATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; SELF REPORT; STATISTICAL ANALYSIS; VIRUS LOAD; VISUAL ANALOG SCALE;

ADULT; AGED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; INDIA; MALE; MEDICATION ADHERENCE; MIDDLE AGED; TREATMENT OUTCOME; VIRAL LOAD; YOUNG ADULT;

EID: 77649217763     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181ba3e4e     Document Type: Letter

References (16)

1. Harrigan PR, Hogg RS, Dong WW, et al. Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis. 2005; 191:339-347.
2. Roge BT, Barfod TS, Kirk O, et al. Resistance profiles and adherence at primary virological failure in three different highly active antiretroviral therapy regimens: analysis of failure rates in a randomized study. HIV Med. 2004;5:344-351.
3. Sethi AK, Celentano DD, Gange SJ, et al. Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clin Infect Dis. 2003;37:1112-1118.
4. Gill CJ, Hamer DH, Simon JL, et al. No room for complacency about adherence to antiretro-viral therapy in sub-Saharan Africa. AIDS. 2005;19:1243-1249.
5. Bangsberg DR, Hecht FM, Charlebois ED, et al. Comparing objective measures of adherence to HIV Antiretroviral therapy: electronic medication monitors and unannounced pill counts. AIDS Behav. 2001;5:275-281.
6. Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134:968-977.
7. Wagner JH, Justice AC, Chesney M, et al. Patient-and provider-reported adherence: toward a clinically useful approach to measuring antiretroviral adherence. J Clin Epidemiol. 2001; 54(Suppl 1):S91-98.
8. Chesney MA. The elusive gold standard. Future perspectives for HIV adherence assessment and intervention. J Acquir Immune Defic Syndr. 2006;43:S149-155.
9. Mills EJ, Nachega JB, Bangsberg DR, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006;3:e438.
10. Giordano TP, Guzman D, Clark R, et al. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials. 2004;5:74-79.
11. Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S79-87.
12. Simoni JM, Kurth AE, Pearson CR, et al. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10:227-245.
13. Shah B, Walshe L, Saple DG, et al. Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India. Clin Infect Dis. 2007;44:1235-1244.
14. Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the AACTG. AIDS Care. 2000;12:255-266.
15. Palmer S, Wiegand AP, Maldarelli F, et al. New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol. 2003;41:4531-4536
16. SPSS for Windows. 15.0.1 ed. Chicago: SPSS Inc; 2006.